SSAT - IMPROVED OVERALL SURVIVAL WITH INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF THE BILE DUCT: ANALYSIS OF A LARGE NATIONAL CANCER REGISTRY
Tumour Budding as an Independent Prognostic Factor for Survival in Patients With Distal Bile Duct Cancer | Anticancer Research
Adding Nab-Paclitaxel to Standard Care Does Not Improve Outcomes in Biliary Tract Cancers - Cancer Therapy Advisor
Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma
A) Disease-free survival curve of 122 patients with distal bile duct... | Download Scientific Diagram
Radiation therapy for recurrent extrahepatic bile duct cancer | PLOS ONE
xmlinkhub
Current Oncology | Free Full-Text | A Population-Based Retrospective Study of Biliary Tract Cancers in Alberta, Canada
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer | NEJM Evidence
Frontiers | The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer
Comparison of the overall-survival rates between hilar... | Download Scientific Diagram
Can bile duct cancer be cured? Survival rates, remission, and more
Cholangiocarcinoma - Bile Duct Cancer - Causes, Symptoms, Treatment
Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin - ScienceDirect
Overall survival rates for patients with distal bile duct cancer after... | Download Scientific Diagram
Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology
Biliary tract cancers: NCDB role in rare malignancy | The Bulletin
Primary tumor resection improves survival in patients with multifocal intrahepatic cholangiocarcinoma based on a population study | Scientific Reports
Survival according to overall tumor stage (f stage) of hilar or... | Download Scientific Diagram
Overall survival stratified by stage group of distal bile duct... | Download Scientific Diagram
Cholangiocarcinoma - "Klatskin's" Tumors of the Bile Duct System - CancerConnect
Medicines | Free Full-Text | PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?
Dual-organ invasion is associated with a lower survival rate than single-organ invasion in distal bile duct cancer: A multicenter study | Scientific Reports
Durvalumab Improves Survival in Bile Duct Cancers - NCI
Cholangiocarcinoma | Nature Reviews Disease Primers
Survival of patients with distal cholangiocarcinoma per stage in a... | Download Scientific Diagram
